Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers
Clinical trial NCT06902103 · COMPLETED
Trial details
- NCT number
- NCT06902103
- Sponsor
- Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-20
- Primary completion
- 2023-12-26
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.